Yongbin Ma

Title: The Innovative Mind of Yongbin Ma: A Patent Profile

Introduction

Yongbin Ma is a prominent inventor based in Hangzhou, China, known for his contributions to the field of pharmaceutical compounds. With a keen focus on developing innovative solutions for treating diseases, Ma has been recognized for his intellectual property rights, particularly in the form of patents.

Latest Patents

Yongbin Ma holds a patent for a crystalline form of a compound that suppresses protein kinase activity. This invention encompasses a novel compound characterized by the structural formula (I) - {5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-6-aminopyridazin-3-yl}-N-{4-[((3S,5R)-3,5-dimethylpiperazinyl)carbonyl]phenyl}carboxamide hydrochloride. The patent details not only the compound itself but also the manufacturing method, related intermediates, and a pharmaceutical composition that leverages the compound for preparing therapeutic products aimed at treating specific diseases, symptoms, or disorders. This patent signifies a significant advancement in pharmaceutical innovations.

Career Highlights

Yongbin Ma is currently associated with Xcovery Holdings, Inc., where he continues to push the boundaries of innovation in the pharmaceutical industry. His role at the company involves research and development of cutting-edge therapeutic solutions that address critical health challenges. His groundbreaking work has not only enriched the company's portfolio but has also contributed notably to the healthcare sector.

Collaborations

Ma's inventive journey is marked by collaborative efforts with his esteemed colleagues, including Congxin Liang and Wei He. Together, they work towards discovering and developing compounds that harness the power of modern science to create effective treatment options.

Conclusion

Yongbin Ma stands as a testament to the spirit of innovation within the pharmaceutical field. His patent for a compound that suppresses protein kinase activity is just one example of how his work is paving the way for new therapeutic strategies. As he continues to collaborate with other talented professionals, the future is bright for advancements that can positively impact public health.